Category Archives: Biotechnology

Neurocore Offers “Ground-Breaking Therapy” To Those Who Suffer From ADHD

Attention Deficit Hyperactivity Disorder (ADHD) is a disorder that interferes with a person’s ability to pay attention and control impulsive behaviors. Another symptom commonly related to this disorder is hyperactivity. Although it is common to have some degree of inattention and unfocused motor activity, people who suffer from ADHD typically experience these situations more severely and with more frequent occurrences.

 

Neurocore’s “Ground-Breaking Therapy”

In an article dated January 21st of 2019, it talks about a “ground-breaking therapy” in treating ADHD. The article begins in saying that the disorder affects children, teens, and adults. To quote, “roughly 4% of U.S. adults suffer from ADHD.” The article also includes a general account of American women who also suffer from the disorder.

The article then talks about treatment options for ADHD and how it “continues to grow.” Outside prescribed medication and conventional therapy, ADHD can now be treated using neurofeedback. The information obtained from neurofeedback can then be used to “create a brain training program” to treat patients suffering from ADHD. The article describes neurotherapy as a type of therapy that “uses real-time electroencephalography (EEG)”. By way of “brainwave sensing electrodes placed on the scalp”, the information extracted by the EEG allows the patient, neuropsychologist, and clinicians to “observe” the brain and, from it, gather key data. This data is then analyzed and is used to customize a treatment or therapy for the patient. The article then moves forward in providing “16 facts” about the new therapy and the company who offers it.

 

Neurocore

Founded in 2004, Neurocore based out of Boca Raton, FL offers its services at their brain performance centers in Michigan and Florida. Headquartered in Michigan, Neurocore has brain performance centers located in Grand Rapids, Livonia, West Bloomfield, Grandville, and Sterling Heights. Outside of Michigan, Neurocore also operates in Boca Raton, Florida.

The company offers treatment and therapy to those who suffer from ADHD, anxiety, and stress to just mention a few. They also offer several programs to treat memory loss. Athletes have also been known to use their services to boost mental strength and stamina.

Dr. Tim Royer is the Founder of Neurocore and Rick Kuiper serves as President. Mark Murrison serves as the company’s Chief Executive Officer, and Dr. Elyse Kemmerer White is the Chief Science Officer.

Next, the article then discusses the details surrounding neurofeedback and neurotherapy. Additionally, the article also includes a detailed discussion about ADHD.

If you would like to view the full article, please click here.

“Marc Beer Renovation in Renovia Company “

Marc Beer is a prominent entrepreneur in the field of medicine and healthcare; he is devoted to establishing new effective treatment methods for many diseases. Recently Marc Beer raised about $42 million to fund the Series B project that entails building Boston-based healthcare center and paying in venture debt. The Boston-based medical center will involve a group of experts devoted and passionate to establish new diagnostic and treatments for various diseases precisely pelvic disorders. According to research, more than 250 million women suffer from pelvic disorders including Urinary incontinence across the globe. Most of the time they are afraid to seek medical support, or at times they cannot afford the charges.

 

Marc Beer identified the need to provide medical care to pelvic disorder patients. During his reign at Renovia Company as the CEO, Marc Beer led the establishment of Leva product which serves several purposes including strengthening and rehabilitating pelvic floor muscles. Leva product is fitted with a kit which supports the pelvic muscles to conduct their functions thus reducing stress; it is preferred compared to surgery since it has no side effects and the instructions for use are indicated to ensure it works efficiently. Leva product has also been approved by the FDA to be fit for consumption.

 

Marc Beer established Boston-based medical center to facilitate research to develop other four different treatment methods for pelvic disorders. In partnership with Longwood company, Marc Beer shares proprietary sensor technologies and expertise to ensure that at the end of the Series B there will be the establishment of a digital platform through which patients are enlightened on various treatment methods. Marc Beer also aims at providing lower long-term costs for treatments, therefore, giving hope to millions of women.

 

Before founding Renovia company, Marc Beer worked in various companies serving top positions; he was the founder of Aegerion company in 2015. He has also worked in OvaScience serving as a strategic consultant for a few years, and before living the company, Marc Beer has transformed the management and established new treatment methods. He believes in teamwork hence works closely with all his employees to ensure they are inspired and also leads by example. Some of the top positions people that Marc Beer works with at Renovia Company include; William Dull who is the Chief Commercial officer, Samantha Pulliam the Chief medical officer, Jessica McKinney the vice president medical affairs and Clinical advocacy, Robin Sutherland, the vice president for Human Resource and clinical operations sector among others.

 

Marc Beer is always in the front line to bring inevitable change at Renovia to ensure every patient is treated with the best standard services and all shareholders get the necessary returns. He is open to change and innovation ideas. Learn more: https://www.benzinga.com/pressreleases/18/08/r12237847/osf-ventures-invests-in-company-developing-solutions-for-pelvic-floor-

 

Marc Beer, Through Renovia, Is Coming Up With More Ways to Treat Women’s Pelvic Disorders

Records show that more than 250 million women in different parts of the globe suffer from pelvic related disorders at certain points of their lives. These disorders include urinary incontinence. These disorders result in pain pressure and incomplete emptying of the bladder that is the main cause of urinary incontinence and frequent urination. Women who suffer from such disorders also have a hard time partaking in sexual activities due to the pain that comes with the illnesses. There have been many companies in the biotechnology industry that are working towards coming up with treatments and therapies to treat these illnesses. One of these companies is Renovia which has in the past been able to get an FDA approval for one of its product aimed at helping the therapy process of treating women pelvic disorders. This product is an application that comes with a Bluetooth device. This application is used in monitoring and encouraging strength training by isolating the weak levator plate muscles and guiding ideal movement patterns in the training. Strength training is a therapeutic approach to the treatment of pelvic disorders. The product is called Leva and it got an FDA approval in April 2018.

 

Funding more research and development in the treatment of women’s pelvic related disorders

 

Following the FDA approval of Leva, Renovia has begun an active program to dig deeper into the issue and come up with more solutions to the disorders. The company Chief Executive Officer embarked on a project to acquire funding for their next project which resulted in him rising up to 42.3 million dollars. This money was raised through a round of fundraising that included 10 million dollars in venture debt and the remaining 32.3 million dollars was obtained through series B equity. The company plans to spend the money on the development of diagnostic and training devices as well as conducting trials and propelling FDA approvals and also commercialization. Marc Beer was a huge part of the fundraising process. Learn more: https://www.crunchbase.com/person/marc-beer

 

About Marc Beer

 

Marc Beer is a graduate of the University of Miami where he got his BS degree in the year 1987. Since then he has been involved in the biotechnology sector for more than two and a half decades. He has found a number of companies in this sector and served in leadership roles in several firms in this industry as well including Aegerion Pharmaceuticals where he was the CEO for five years. He founded Renovia in the year 2016 and has been the chairman and CEO of the company since then.